1. Home
  2. SNGX vs SOS Comparison

SNGX vs SOS Comparison

Compare SNGX & SOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.37

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

Logo SOS Limited

SOS

SOS Limited

HOLD

Current Price

$1.22

Market Cap

10.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
SOS
Founded
1987
2004
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
11.2M
10.7M
IPO Year
2006
2005

Fundamental Metrics

Financial Performance
Metric
SNGX
SOS
Price
$1.37
$1.22
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
239.5K
63.0K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
57.03
N/A
EPS
N/A
N/A
Revenue
$119,371.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.90
52 Week High
$6.23
$8.92

Technical Indicators

Market Signals
Indicator
SNGX
SOS
Relative Strength Index (RSI) 68.53 55.41
Support Level $1.19 $1.15
Resistance Level $1.47 $1.56
Average True Range (ATR) 0.05 0.13
MACD 0.03 0.04
Stochastic Oscillator 80.30 71.11

Price Performance

Historical Comparison
SNGX
SOS

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About SOS SOS Limited

SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.

Share on Social Networks: